Literature DB >> 9530183

Basal metabolism does not account for high O2 consumption in stunned myocardium.

J D Schipke1, B Korbmacher, U Schwanke, D Frehen, T Schmidt, G Arnold.   

Abstract

Myocardial O2 consumption (MVo2) in stunned myocardium is relatively high compared with the reduced ventricular function. The mechanism of this "oxygen paradox" could occur at different levels: basal metabolism, excitation-contraction coupling, and energy production. In one previously reported series on 12 isolated, blood-perfused rabbit hearts, left ventricular systolic and diastolic function in stunned myocardium were significantly decreased compared with control, whereas total MVo2 was not. The MVo2 for the unloaded contraction was overproportionately high for the decreased function in stunned myocardium, and contractile efficiency was clearly deteriorated. To assess whether the basal metabolism specifically is elevated in stunned myocardium, a second series (n = 14) with a similar protocol was performed in this study. Basal MVo2 after KCl arrest (0.5 +/- 0.3 ml.min-1.100 g-1) was significantly lower than that measured after KCl arrest (1.2 +/- 0.5 ml.min-1.100 g-1) in an additional series on nonischemic hearts (n = 8). Our conclusion is that basal MVo2 in stunned myocardium is not elevated. Thus this O2-consuming portion of total MVo2 is not responsible for the inefficiency in stunned myocardium. Instead, a "metabolic stunning" occurs at the level of both excitation-contraction coupling and force development by the contractile apparatus.

Entities:  

Mesh:

Year:  1998        PMID: 9530183     DOI: 10.1152/ajpheart.1998.274.3.H743

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

Review 1.  Myocardial stunning in man.

Authors:  Edward Barnes; Masood A Khan
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

2.  Regional QT Interval Dispersion as an Early Predictor of Reperfusion in Patients with Acute Myocardial Infarction after Fibrinolytic Therapy.

Authors:  Gabriel Dotta; Francisco Antonio Helfenstein Fonseca; Maria Cristina de Oliveira Izar; Marco Tulio de Souza; Flavio Tocci Moreira; Luiz Fernando Muniz Pinheiro; Adriano Henrique Pereira Barbosa; Adriano Mendes Caixeta; Rui Manoel Santos Póvoa; Antônio Carlos Carvalho; Henrique Tria Bianco
Journal:  Arq Bras Cardiol       Date:  2018-12-17       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.